CAS: 1640972-35-5
5,6-DihydroCP-690550
CAS:1640972-35-5
Formula:
C16H22N6O
Purity:
95%
Color and Shape:
Solid
Molecular weight:
314.3855
Ref: IN-DA01E2LS
| 10mg | To inquire | ||
| 25mg | To inquire | ||
| 100mg | To inquire |
Estimated delivery in United States, on Tuesday 7 Jan 2025
Tofacitinib Related Compound 21
CAS:1640972-35-5
Formula:
C16H22N6O
Color and Shape:
Pale Yellow Solid
Molecular weight:
314.39
Ref: 4Z-T-117050
| 10mg | To inquire | ||
| 25mg | To inquire | ||
| 50mg | To inquire | ||
| 100mg | To inquire |
Estimated delivery in United States, on Tuesday 7 Jan 2025
5,6-Dihydro CP-690550
Controlled ProductCAS:1640972-35-5
Applications 5,6-Dihydro CP-690550 is an impurity of CP-690550 (C781350), a pyrrolo[2,3-d]pyrimidine derivative, as Janus kinase …
Formula:
C16H22N6O
Color and Shape:
Neat
Molecular weight:
314.39
Ref: TR-D450240
| 5mg | 320.00 € | ||
| 25mg | 1,328.00 € | ||
| 50mg | 2,118.00 € |
Estimated delivery in United States, on Wednesday 15 Jan 2025
Tofacitinib impurity
CAS:1640972-35-5
Tofacitinib impurity is a pharmacopoeia grade synthetic tofacitinib impurity intended for the manufacture of drug …
Purity:
Min. 95%
Molecular weight:
314.39 g/mol
Ref: 3D-IT182479
| 1mg | 310.00 € | ||
| 2mg | 465.00 € | ||
| 5mg | 647.00 € | ||
| 10mg | 1,047.00 € | ||
| 25mg | 2,087.00 € |
Estimated delivery in United States, on Tuesday 18 Feb 2025
Tofacitinib dihydro impurity
CAS:1640972-35-5
Tofacitinib dihydro impurity is a research and development impurity standard for the synthesis of Tofacitinib. …
Formula:
C16H22N6O
Purity:
Min. 95%
Molecular weight:
314.39 g/mol
Ref: 3D-QQC97235
| 25mg | 986.00 € | ||
| 50mg | 1,392.00 € | ||
| 100mg | 1,855.00 € | ||
| 250mg | 2,319.00 € | ||
| 500mg | 3,015.00 € |
Estimated delivery in United States, on Tuesday 4 Mar 2025
